Cargando…

Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS

BACKGROUND: Whether airspace biomarkers add value to plasma biomarkers in studying acute respiratory distress syndrome (ARDS) is not well understood. Mesenchymal stromal cells (MSCs) are an investigational therapy for ARDS, and airspace biomarkers may provide mechanistic evidence for MSCs’ impact in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wick, Katherine D., Leligdowicz, Aleksandra, Zhuo, Hanjing, Ware, Lorraine B., Matthay, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2021
Materias:	Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262503/ https://www.ncbi.nlm.nih.gov/pubmed/33974564 http://dx.doi.org/10.1172/jci.insight.148983

Ejemplares similares

Is there still a role for the lung injury score in the era of the Berlin definition ARDS?
por: Kangelaris, Kirsten Neudoerffer, et al.
Publicado: (2014)

Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury
por: McClintock, Dana, et al.
Publicado: (2008)

Carbonic Anhydrase IX: Scaring Away the Grim Reaper in Acute Lung Injury?
por: Leligdowicz, Aleksandra, et al.
Publicado: (2021)

Designing an ARDS trial for 2020 and beyond: focus on enrichment strategies
por: Ware, Lorraine B., et al.
Publicado: (2020)

Heterogeneity in sepsis: new biological evidence with clinical applications
por: Leligdowicz, Aleksandra, et al.
Publicado: (2019)

Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis
por: Rosenberger, Carrie M., et al.
Publicado: (2023)

Pulse oximetry for the diagnosis and management of acute respiratory distress syndrome
por: Wick, Katherine D, et al.
Publicado: (2022)

The endogenous capacity to produce proinflammatory mediators by the ex vivo human perfused lung
por: Leligdowicz, Aleksandra, et al.
Publicado: (2020)

Derivation and validation of a two-biomarker panel for diagnosis of ARDS in patients with severe traumatic injuries
por: Ware, Lorraine B, et al.
Publicado: (2017)

Circulating microparticle levels are reduced in patients with ARDS
por: Shaver, Ciara M., et al.
Publicado: (2017)

Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome
por: Liu, Kathleen D, et al.
Publicado: (2014)

Promises and challenges of personalized medicine to guide ARDS therapy
por: Wick, Katherine D., et al.
Publicado: (2021)

RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19
por: Wick, Katherine D., et al.
Publicado: (2022)

Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis
por: Ouboter, Laura F., et al.
Publicado: (2023)

Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS
por: Xu, Zhiheng, et al.
Publicado: (2021)

Proinflammatory cytokines and ARDS pulmonary edema fluid induce CD40 on human mesenchymal stromal cells—A potential mechanism for immune modulation
por: Wilfong, Erin M., et al.
Publicado: (2020)

A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome
por: Vivarelli, Marina, et al.
Publicado: (2023)

Biological Mechanisms of COVID-19 Acute Respiratory Distress Syndrome
por: Matthay, Michael A., et al.
Publicado: (2020)

The role of red blood cells and cell-free hemoglobin in the pathogenesis of ARDS
por: Janz, David R, et al.
Publicado: (2015)

Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis
por: Wilson, Jennifer G., et al.
Publicado: (2020)

Accuracy of the Radiographic Assessment of Lung Edema Score for the Diagnosis of ARDS
por: Zimatore, Claudio, et al.
Publicado: (2021)

Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS
por: Jackson, Megan V., et al.
Publicado: (2016)

The prognostic value of early measures of the ventilatory ratio in the ARDS ROSE trial
por: Monteiro, Ana Carolina Costa, et al.
Publicado: (2022)

Editorial: Personalized therapy in ARDS
por: Battaglini, Denise, et al.
Publicado: (2023)

Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): Current understanding and future perspectives
por: Su, Yue, et al.
Publicado: (2021)

PDGFRα/Sca-1 Sorted Mesenchymal Stromal Cells Reduce Liver Injury in Murine Models of Hepatic Ischemia-Reperfusion Injury
por: Owen, Andrew, et al.
Publicado: (2022)

Latent Class Analysis-Derived Subphenotypes are Generalizable to Observational Cohorts of Acute Respiratory Distress Syndrome: A Prospective Study
por: Sinha, Pratik, et al.
Publicado: (2021)

Clinical significance of elevated B-type natriuretic peptide in patients with acute lung injury with or without right ventricular dilatation: an observational cohort study
por: Cepkova, Magda, et al.
Publicado: (2011)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
por: Wang, Fengyun, et al.
Publicado: (2023)

Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection
por: Leligdowicz, Aleksandra, et al.
Publicado: (2017)

Fluid management in acute lung injury and ards
por: Roch, Antoine, et al.
Publicado: (2011)

Decreased respiratory system compliance on the sixth day of mechanical ventilation is a predictor of death in patients with established acute lung injury
por: Seeley, Eric J, et al.
Publicado: (2011)

Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS
por: Hendrickson, Carolyn M., et al.
Publicado: (2018)

Transcriptomic evidence of lung repair in paediatric ARDS survival
por: Song, Licheng, et al.
Publicado: (2023)

Plasma Metabolites in Early Sepsis Identify Distinct Clusters Defined by Plasma Lipids
por: Rogers, Angela J., et al.
Publicado: (2021)

Mesenchymal Stromal Cell Extracellular Vesicles: A New Approach for Preventing Bronchopulmonary Dysplasia?
por: Klinger, James R., et al.
Publicado: (2022)

Diagnostic workup for ARDS patients
por: Papazian, Laurent, et al.
Publicado: (2016)

Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
por: Monsel, Antoine, et al.
Publicado: (2022)

Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
por: Zarrabi, Morteza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9nb1bl4rvspr124h2q3cfd78r6